Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
09
2026

Is There an Alternative to Mohs Surgery for Non-Melanoma Skin Cancer?

Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…

December
04
2020

Basal Cell Carcinoma Treatment Anaheim California

Basal and Squamous Cell Carcinoma Treatment in Anaheim, CA If you are looking for a the best non-melanoma skin cancer treatment in Anaheim, California, then while of course you’d rather not be in the position…

December
01
2020

Sensus Healthcare Announces Study Showing Single Low Dose of Superficial Radiation Therapy Prevents Keloid Recurrence Following Surgical Excision

Prospective study published in Journal of the American Academy of Dermatology BOCA RATON, Dec. 01, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments…

December
01
2020

Sensus Healthcare Announces Study Showing Single Low Dose of Superficial Radio Therapy Prevents Keloid Recurrence Following Surgical Excision

Prospective study published in Journal of the American Academy of Dermatology BOCA RATON, Dec. 01, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments…

November
23
2020

Single Dose of SRT To Treat Recurrence After Surgical Excision: An In Vitro & In Vivo Study

A new study on Superficial Radio Therapy (SRT) shows that a single dose can be used to treat recurrence of keloid scarring after surgical excision. This study was conducted on fifteen patients with 20 untreated…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry